Dover Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,403
Closed -$283K 114
2023
Q4
$283K Sell
3,403
-1,329
-28% -$101K 0.37% 70
2023
Q3
$374K Hold
4,732
0.38% 72
2023
Q2
$420K Sell
4,732
-309
-6% -$26.6K 0.37% 72
2023
Q1
$410K Buy
5,041
+194
+4% +$15.8K 0.39% 68
2022
Q4
$380K Buy
+4,847
New +$393K 0.41% 68

Other funds holding MDT

Dover Advisors's MDT Position: Q1 2024 in Review

Dover Advisors sold out of Medtronic (MDT) in Q1 2024, closing a stake of 3,403 shares — an estimated $283K sold.

Dover Advisors first reported a position in MDT in Q4 2022 and held it in 5 quarters. The position peaked at $420K in Q2 2023. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Dover Advisors reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Dover Advisors sold 3,403 Medtronic shares in Q1 2024, an estimated $283K.
  • Dover Advisors first reported a position in Medtronic in Q4 2022 and held it in 5 quarters.
  • Dover Advisors's Medtronic position peaked at $420K in Q2 2023.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Dover Advisors's 13F filing for Q1 2024, filed 29 Apr 2024.